Screener
Tango Therapeutics TNGX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
FAQ
- What is Tango Therapeutics's enterprise value?
- Tango Therapeutics (TNGX) reported enterprise value of $2.86B in Q1 2026.
- How has Tango Therapeutics's enterprise value changed year-over-year?
- Tango Therapeutics's enterprise value increased by 2203.7% year-over-year, from $124.05M to $2.86B.
- What is the long-term trend for Tango Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), Tango Therapeutics's enterprise value has grown at a 2.0% compound annual growth rate (CAGR), from $1.01B to $1.11B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Tango Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude